Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

GameStop Stock Is Showing Signs of Weakness as Short-Sellers Lose Interest

Redditors are looking elsewhere after vanquishing Wall Street and giving GME a fighting chance, leaving the stock in a difficult position.

Troubling Times Ahead for Zoom in the Post-Pandemic World

ZM stock trades at a lofty valuation despite the significant slowdown predicted in revenue and earnings growth.

The Outlook of Clover Stock Is Deteriorating

CLOV stock has been a disappointment for many reasons. Given the company's poor fundamentals, it's not worth investing in.

Unusual Acquisition Could Help Fiverr Stock Break Through $200

The skeptics might say Fiverr should stick to facilitating gig work. Yet, FVRR stock holders should appreciate the company's new ambitions.

Ocugen Stock Needs a Catalyst for Growth That Probably Isn’t Coming

InvestorPlace’s Louis Navellier believes all Ocugen needs is a catalyst. On Oct. 4, OCGN stock got two. Its share price barely moved. 

Lemonade Remains a Cautionary Tale of Tech Updating Old Industry

Lemonade promised more than it could deliver and profitability issues remain more than a year after its IPO. LMND stock has gone sour.

4 Stocks to Sell (and 4 to Buy) Amid Facebook’s Whistleblower Scandal

With the Facebook scandal possibly forcing a greater response by social media, here are the stocks to sell (and buy) from the PR crisis.

Vinco Ventures Doesn’t Look Any Better After This M&A Announcement

Vinco Ventures made a big acquisition causing BBIG stock to jump almost 20%. However, the rally was short-lived. Here’s why that’s the case. 

Don’t Buy Too Much Into the WHO Hype Surrounding Ocugen Stock

Admittedly, one last boost may still be on the table, if meme traders use subsequent WHO news as reason to send OCGN stock back to double-digit prices. But with its high chances of ultimately collapsing in price, it's a stock most investors should avoid.

Novavax Stock Will Find Its Bottom, But Probably not Soon

Down nearly 40% over the past month, NVAX stock has been on a steep decline that appears to be accelerating. At its current price of $163.06 per share, Novavax's stock is now 50% below its all-time high of $331.68 reached in February of this year. With the current slide showing no signs of stopping, shareholders may want to cut their losses.

Avoid ChargePoint Stock Until It’s Completely Out of Favor

CHPT stock will likely continue to trend lower, even if the shares' political and market headwinds eventually end.

Meta Materials Is Overpriced After Paying Too Much for Nanotech Security

MMAT stock is not worth more than 87 cents per share after Meta Materials overpaid for its recent acquisition of Nanotech Security.

Why It’s Time to Walk Away From Peloton Interactive Stock

Don't try to bottom-fish for value with beaten-down PTON stock as the company's revenue streams aren't translating into bottom-line returns.

Boeing Still Hasn’t Had the Promised Turnaround, and It May Not Come

Boeing today is as troubled as it was when Dave Calhoun was named CEO nearly two years ago, and the rot has spread throughout the company.

Hippo Holdings Suffrers From Much More Than Generalized SPAC Exhaustion

While HIPO stock is connected to the relevant tech-based insurance services sector, economic challenges pose serious concerns.

Despite ‘BBIG’ Promises, Vinco Ventures Charts a Familiar Path

Although BBIG stock is theoretically buoyed by relevant acquisitions, the market doesn’t have the same confidence as the bulls about Vinco Ventures.

Lucid Group Got a Nice Boost, But There’s No Reason to Go All In

EV stocks are a very exciting sector right now, but this may well be the high water mark for many, including LCID stock.

You Really Should Have Sold Nio Stock by Now

NIO stock remains a sell as the markets continue shedding weight on Chinese stocks. Key metrics suggest that the stock is a must sell.

Elevated Valuations Could Cause Problems for Cowen Stock

Financial services company Cowen has seen key segment growth slow down, which in turn has caused COWN stock to be overvalued.